Mobile Menu

Search Results

Search results for: Medicines

Overview of drug repositioning

A recent review, published in the Journal of Pharmacy and Pharmacology, provides an overview of drug repositioning and the new […]

Pharma data as an asset: how to become information centric

Whilst the life sciences and biopharmaceutical industries are moving to a more data driven approach in their research, data is […]

How is AI accelerating drug development?

The first entirely AI-developed drug candidate, DSP-1181, entered Phase I clinical trials in Japan earlier this year, having been discovered […]

Calls for global collaboration in Real World Evidence use

Expert panellists have called for a global effort to harmonise the acceptance of Real World Evidence (RWE), to aid clinical […]

EubOPEN consortium to provide open-source cheminformatics tools for one third of druggable proteins

The chemistry services team at EMBL has announced that they will provide an informatics infrastructure to the IMI-funded EUbOPEN Consortium […]

Interview with Seven Bridges: Bill Moss, CEO & Brandi Davis- Dusenbery, CSO: What the future holds for big data

Front Line Genomics recently caught up with Bill Moss, CEO, and Brandi Davis-Dusenbery, CSO, of Seven Bridges to hear their […]

Gero’s AI platform identifies 9 approved potential anti-Covid-19 drugs

Gero, the so-called longevity biotech has announced that their proprietary platform has identified a number of potential drugs to treat […]

Foundations for AI are “Critical” to our Continued Success – Interview with Dr Paul Agapow, AstraZeneca

FLG: Could you introduce yourself and the work you do? I am currently a Health Informatics Director at AstraZeneca. I […]

Interview with Dr Michelle Krishnan, Translational Medicine Leader in rare diseases, Roche

FLG: Could you introduce yourself and tell us about the work you are currently doing at Roche? I am a […]